112 related articles for article (PubMed ID: 8246033)
1. Low-dose gallium nitrate for prevention of osteolysis in myeloma: results of a pilot randomized study.
Warrell RP; Lovett D; Dilmanian FA; Schneider R; Heelan RT
J Clin Oncol; 1993 Dec; 11(12):2443-50. PubMed ID: 8246033
[TBL] [Abstract][Full Text] [Related]
2. Effect of pamidronate on skeletal morbidity in myelomatosis. Part 1. The results of the first 12 months of pamidronate therapy.
Kraj M; Pogłód R; Pawlikowski J; Maj S; Nasiłowska B
Acta Pol Pharm; 2000 Nov; 57 Suppl():113-6. PubMed ID: 11293237
[TBL] [Abstract][Full Text] [Related]
3. Comparative evaluation of safety and efficacy of pamidronate and zoledronic acid in multiple myeloma patients (single center experience).
Kraj M; Pogłód R; Maj S; Pawlikowski J; Sokołowska U; Szczepanik J
Acta Pol Pharm; 2002; 59(6):478-82. PubMed ID: 12669777
[TBL] [Abstract][Full Text] [Related]
4. Gallium nitrate for acute treatment of cancer-related hypercalcemia. A randomized, double-blind comparison to calcitonin.
Warrell RP; Israel R; Frisone M; Snyder T; Gaynor JJ; Bockman RS
Ann Intern Med; 1988 May; 108(5):669-74. PubMed ID: 3282463
[TBL] [Abstract][Full Text] [Related]
5. A randomized double-blind study of gallium nitrate compared with etidronate for acute control of cancer-related hypercalcemia.
Warrell RP; Murphy WK; Schulman P; O'Dwyer PJ; Heller G
J Clin Oncol; 1991 Aug; 9(8):1467-75. PubMed ID: 1906532
[TBL] [Abstract][Full Text] [Related]
6. Long-term pamidronate treatment of advanced multiple myeloma patients reduces skeletal events. Myeloma Aredia Study Group.
Berenson JR; Lichtenstein A; Porter L; Dimopoulos MA; Bordoni R; George S; Lipton A; Keller A; Ballester O; Kovacs M; Blacklock H; Bell R; Simeone JF; Reitsma DJ; Heffernan M; Seaman J; Knight RD
J Clin Oncol; 1998 Feb; 16(2):593-602. PubMed ID: 9469347
[TBL] [Abstract][Full Text] [Related]
7. Gallium nitrate in multiple myeloma: prolonged survival in a cohort of patients with advanced-stage disease.
Niesvizky R
Semin Oncol; 2003 Apr; 30(2 Suppl 5):20-4. PubMed ID: 12776256
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of pamidronate in reducing skeletal events in patients with advanced multiple myeloma. Myeloma Aredia Study Group.
Berenson JR; Lichtenstein A; Porter L; Dimopoulos MA; Bordoni R; George S; Lipton A; Keller A; Ballester O; Kovacs MJ; Blacklock HA; Bell R; Simeone J; Reitsma DJ; Heffernan M; Seaman J; Knight RD
N Engl J Med; 1996 Feb; 334(8):488-93. PubMed ID: 8559201
[TBL] [Abstract][Full Text] [Related]
9. Gallium nitrate inhibits calcium resorption from bone and is effective treatment for cancer-related hypercalcemia.
Warrell RP; Bockman RS; Coonley CJ; Isaacs M; Staszewski H
J Clin Invest; 1984 May; 73(5):1487-90. PubMed ID: 6715548
[TBL] [Abstract][Full Text] [Related]
10. Gallium nitrate for acute treatment of cancer-related hypercalcemia: clinicopharmacological and dose response analysis.
Warrell RP; Skelos A; Alcock NW; Bockman RS
Cancer Res; 1986 Aug; 46(8):4208-12. PubMed ID: 3731088
[TBL] [Abstract][Full Text] [Related]
11. Treating cancer-related hypercalcemia with gallium nitrate.
Leyland-Jones B
J Support Oncol; 2004; 2(6):509-16. PubMed ID: 15605917
[TBL] [Abstract][Full Text] [Related]
12. Effect of daily etidronate on the osteolysis of multiple myeloma.
Belch AR; Bergsagel DE; Wilson K; O'Reilly S; Wilson J; Sutton D; Pater J; Johnston D; Zee B
J Clin Oncol; 1991 Aug; 9(8):1397-402. PubMed ID: 1712835
[TBL] [Abstract][Full Text] [Related]
13. Functional outcomes and height restoration for patients with multiple myeloma-related osteolytic vertebral compression fractures treated with kyphoplasty.
Julka A; Tolhurst SR; Srinivasan RC; Graziano GP
J Spinal Disord Tech; 2014 Aug; 27(6):342-6. PubMed ID: 22668752
[TBL] [Abstract][Full Text] [Related]
14. [Neurologic sequelae of bone changes in multiple myeloma and its therapy].
Basić-kes V; Basić-Jukić N; Kes P; Demarin V; Labar B
Acta Med Croatica; 2002; 56(3):103-7. PubMed ID: 12630341
[TBL] [Abstract][Full Text] [Related]
15. A multicenter trial of low dose gallium nitrate in patients with advanced Paget's disease of bone.
Bockman RS; Wilhelm F; Siris E; Singer F; Chausmer A; Bitton R; Kotler J; Bosco BJ; Eyre DR; Levenson D
J Clin Endocrinol Metab; 1995 Feb; 80(2):595-602. PubMed ID: 7852526
[TBL] [Abstract][Full Text] [Related]
16. Phase II randomized trial of gallium nitrate plus fluorouracil versus methotrexate, vinblastine, doxorubicin, and cisplatin in patients with advanced transitional-cell carcinoma.
McCaffrey JA; Hilton S; Mazumdar M; Sadan S; Heineman M; Hirsch J; Kelly WK; Scher HI; Bajorin DF
J Clin Oncol; 1997 Jun; 15(6):2449-55. PubMed ID: 9196161
[TBL] [Abstract][Full Text] [Related]
17. Subgroup and cost-benefit analysis of the Finnish multicentre trial of clodronate in multiple myeloma. Finnish Leukaemia Group.
Laakso M; Lahtinen R; Virkkunen P; Elomaa I
Br J Haematol; 1994 Aug; 87(4):725-9. PubMed ID: 7986713
[TBL] [Abstract][Full Text] [Related]
18. Phase II evaluation of gallium nitrate by continuous infusion in breast cancer.
Jabboury K; Frye D; Holmes FA; Fraschini G; Hortobagyi G
Invest New Drugs; 1989 Jul; 7(2-3):225-9. PubMed ID: 2793377
[TBL] [Abstract][Full Text] [Related]
19. Gallium nitrate for the treatment of bone metastases.
Warrell RP
Cancer; 1997 Oct; 80(8 Suppl):1680-5. PubMed ID: 9362436
[TBL] [Abstract][Full Text] [Related]
20. Kyphoplasty in the treatment of osteolytic vertebral compression fractures as a result of multiple myeloma.
Dudeney S; Lieberman IH; Reinhardt MK; Hussein M
J Clin Oncol; 2002 May; 20(9):2382-7. PubMed ID: 11981012
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
